I migliori medici per il trattamento di Metastasi epatiche - TOP-68 medici

Classificato al primo posto nell'esame di oncologia medica della Turchia – il Dr. Keskin porta oltre 28 anni di esperienza nel trattamento delle metastasi epatiche presso il Memorial Şişli.

• Eseguito oltre 900 procedure oncologiche
• Premio Miglior Poster al 19° Congresso Nazionale del Cancro
• Membro di ASCO ed ESMO – si mantiene aggiornato sui protocolli globali
• Specializzato in chemioterapia, terapia mirata e immunoterapia

La Dott.ssa Eda Tanrikulu dirige l'Oncologia Medica presso l'Anadolu Medical Center, specializzandosi nel trattamento del cancro con 17 anni di esperienza.

• Classificata al 3° posto in Turchia per la specializzazione in oncologia medica
• Ha guidato le unità di oncologia medica presso l'Ospedale di Formazione e Ricerca Haydarpaşa Numune
• Assistente e ricercatrice principale in studi clinici internazionali
• Specializzata in oncologia medica e chemioterapia

Oltre 900 procedure eseguite – Il Dott. Solak è specializzato in casi complessi di cancro presso l'Ospedale Intercontinentale Hisar.

• 19 anni di esperienza in oncologia
• Formazione di specializzazione presso l'Istituto dei Tumori dell'Università di Hacettepe
• Esperienza clinica presso il MD Anderson Cancer Center
• Specializzato in tumori al seno, polmonari e gastrointestinali

Il Prof. Peker ha eseguito oltre 200 interventi chirurgici al fegato, specializzandosi in procedure epatopancreatobiliari presso l'Hisar Hospital Intercontinental.

• Formazione presso la Mayo Clinic in Chirurgia Epatopancreatobiliare
• Fondatore dell'unità di Chirurgia Epatopancreatobiliare presso l'ospedale Bakırköy Dr. Sadi Konuk
• Specializzato in Chirurgia del Cancro al Fegato e Malattie del Pancreas
• Ha eseguito oltre 400 interventi chirurgici per cancro del pancreas e dello stomaco

Assoc. Prof. Gorkem Turkkan started his medical education at Gülhane Military Medical Academy in 2003 and completed it at Zonguldak Karaelmas (Bülent Ecevit) University Faculty of Medicine in 2009. He completed his specialization at Trakya University Faculty of Medicine, Department of Radiation Oncology and became a radiation oncology specialist in 2016.

After completing his compulsory service, he served as a Lecturer and Head of Department at Muğla Sıtkı Koçman University Faculty of Medicine, Department of Radiation Oncology, from May 2019 to February 2021. Meanwhile, between March and June 2020, he worked as a clinical researcher at Maastricht University Faculty of Medicine Department of Radiation Oncology – MAASTRO Clinic (Netherlands) on stereotactic radiotherapy, thoracic radiotherapy-related lung toxicity and proton therapy. While he was working at İstinye University Faculty of Medicine, Department of Radiation Oncology and Liv Hospital Ulus Radiation Oncology Clinic between March 2021 and April 2023, he received the title of Associate Professor in February 2023. She has been serving her patients at Hisar Hospital Intercontinental since May 2023.

He has performed both traditional radiotherapy and advanced radiotherapy throughout his career. He is one of the experienced physicians in our country in stereotactic radiotherapy and MRI-guided radiotherapy treatments, which have become increasingly popular and used especially recently. So far, he has successfully completed more than 2500 radiotherapy sessions with the MR-Linac device.

He has been a member of the Turkish Society of Radiation Oncology (TROD) since 2013 and the European Society of Radiotherapy and Oncology (ESTRO) since 2015. He has 27 articles published in domestic and international journals, 31 oral-poster presentations presented at national and international congresses, and 5 book chapters published by national and international publishing houses. He taught Term I and Term V undergraduate courses at Muğla Sıtkı Koçman University Faculty of Medicine, postgraduate courses within the scope of Ear Nose and Throat Department Specialization training, and Radiotherapy associate degree courses at İstinye University Vocational School of Health Services. She is currently working on 2 ongoing TÜBİTAK Projects. He is married and has a son.

MEDICAL INTERESTS

MR-Linac

Linac

Stereotactic (Pinpoint) Radiotherapy

Prostate Cancers

Breast Cancers

Lung Cancers

Rectum Cancers

Brain and Spinal Cord Cancers

Head and Neck Cancers

Volumetric Arc Therapy (VMAT)

Intensity Modulated Radiotherapy (IMRT)

La Dott.ssa Pelles Sharon dirige l'Istituto dei Tumori Gastrointestinali presso il Centro Medico Sourasky, leader nel trattamento delle metastasi epatiche.

• Specializzata nel trattamento sistemico dei tumori gastrointestinali
• Formata in oncologia presso il Royal Marsden Cancer Center di Londra
• Ha sviluppato nuovi metodi per il trattamento dell'adenocarcinoma pancreatico
• Ha condotto ricerche molecolari rivoluzionarie sui tumori delle vie biliari

Il Prof. Merimsky dirige l'Unità di Oncologia dei Tessuti Molli e delle Ossa presso il Sourasky Medical Center, uno dei principali centri oncologici di Israele.

• Oltre 20 anni di esperienza specializzata in oncologia ortopedica
• Fellowship nel trattamento dei sarcomi presso l'Institut Gustave Roussy, Parigi
• Ricercatore senior presso il Weizmann Institute e l'Università di Tel Aviv
• Membro attivo dell'ESMO nella facoltà di sarcomi
• Ha pubblicato numerosi studi sui risultati del trattamento del cancro

Doctor Brenda Pastrana is a mexican surgical Oncologist. 

Medical background.

Centro Medico Nacional 20 de Noviembre Issste, Surgical Oncologist in 2020.

Title by Universidad Autónoma de México UNAM.

Surgical Residency Instituto Mexicano del Seguro Social. 2015.

Title by Universidad de Quintana Roo. 

Board Certified by Conacem from 2020 to 2025 number 2171 

Board Certified by Conacem from 2025 to 2030 number 2171

Member of SMEO. Sociedad Mexicana de Oncología. 

University teacher at Universidad Anahuac of Medicine since 2020.

Il Dott. Seifert dirige il Centro per il Cancro al Seno di Solingen, specializzato in interventi di chirurgia conservativa del seno e ricostruzioni estetiche da oltre 20 anni.

• Esperto in diagnosi precoce e trattamenti innovativi
• Abile nelle tecniche di ricostruzione plastica
• Fornisce supporto psicologico durante tutto il trattamento
• Dirige uno dei principali centri per il cancro al seno di Solingen

Activities • Prevention, research and early diagnosis of cancer • Palliative care in cancer • Cytotoxic chemotherapy • Hormontherapy • Targeted treatment • Immunotherapy Education • 2004 -2010 - Istanbul University, Istanbul faculty of medicine • 2011-2015 - Istanbul University, Istanbul faculty of medicine, internal medicine specialist • 2013-2014 - Cleveland Clinic Endocrinology Department, research associate • 2016-2019 Bezmiâlem Foundation University Medical Oncology Subdivision • Dissertation: Prognostic value of absolute monocyte count in patients with mantle cell lymphoma. • Subdivision Dissertation: An effect of adjuvant chemotherapy on lipid profile and anthropometric parameters in patients with breast and colon cancer. Publications • Circulating Thyroid-Stimulating Hormone Receptor Messenger RNA as a Marker of Tumor Aggressiveness in Patients with Papillary Thyroid Microcarcinoma. Aliyev A, Gupta M, et al. Endocr  18. • The utility of peripheral thyrotropin receptor mRNA in the management of differentiated thyroid cancer. • Aliyev A, Soundararajan S, Bucak E et al. Surgery.  • Diagnostic accuracy of circulating thyrotropin receptor messenger RNA combined with neck ultrasonography in patients with Bethesda III-V thyroid cytology. Aliyev A, Patel J, Brainard J, et al. Surgery.2016 Jan;159(1):113-7. doi: 10.1016/j.surg.2015.06.063. Epub 2015 Oct 9. • Role of Urotensin-2 in 5-Fluorouracil-Related Arterial Vasoconstriction in Cancer Patients. Seker M, Aliyev A, et al. Oncol Res Treat. Epub 2018 Aug 20. • Pertuzumab, trastuzumab and taxane-based treatment for visceral organ metastatic, trastuzumab-naive breast cancer: real-life practice outcomes. Esin E, Oksuzoglu B, Bilici A, Aliyev A. Cancer Chemother Pharmacol.2019 Jan; Epub 2018 Oct 30. • Usefulness of serum M30 and M65 levels to predict response to neoadjuvant chemotherapy in patients with breast cancer. Turk HM, Aliyev A, Celik RS. Curr Probl Cancer.2019 Jul 29. pii: currproblcancer.2019.06.009. • Prognostic impact of primary tumor location on survival in metastatic colorectal cancer patients: A single center experience. Tarik Demir, Murat Araz, Altay Aliyev. Medicine Science International Medicine Journal. • Oral presentations 

Head of Teaching at the Puerto Vallarta Regional Hospital

2020-2023

Medical records manager at the Regional Hospital of Puerto Vallarta 2 months 2020

General practitioner in private medical office

2015-2022

Doctor in charge of weight control clinic

2013-2014

Medical assistant in dermatology clinic

2008-2013

Medical Assistant in Dermatological procedures.

 Medical Assistant in minimally invasive surgical procedures

 Operation of fractional laser machine - IPIXEL-ER and

facial rejuvenation with IPL.

 Experience in laser hair removal with Intense Pulsed Light and

radiofrequency

 Experience with ultrasonic cavitation

 Experience with ultraviolet (UV) light phototherapy machine for the

treatment of psoriasis and vitiligo.

 Experience assisting in Botox and Fillers procedures.

 Biomagnet certified by the Higher Institute of Biomagnetism

doctor ISAAC GOIZ DURAN

 Experience in clinical records

 Training in continuing education and professional development of teachers

Personal Information 

Sex:  Male

Born : 1968 

Professional Experience

Gayrettepe Florence Nigthingale Hospital

Medical Oncology Department

Besiktas/Istanbul/Turkey (ongoing)

Education:

He became Professor (22/April /2016)

Medical Oncology

Attending Phys.in Gastrointestinal Oncology (January 2005 ,2009)

Istanbul University Oncology Institue,

Department of Medical Oncology

Medical Oncology Fellowship (December 2001-December2004)

Istanbul University, Istanbul Medical Faculty

Hemodialysis Traning (May1996-January1997)

Istanbul University ,bCerrahpasa Medical Faculty

Internal Medicine Residency (November 1991-November 1996)

Istanbul University ,bCerrahpasa Medical Faculty

Ege University Medical Faculty (1985-1991)

Professional Experience

February 1999-November 2001

Metropolitan Florence Nigthingale Hospital

American Cancer Center, Gayrettepe/İstanbul

April1997- October 1998

Bayraktar Dialysis Center

Güngören/ Istanbul

Membership

Turkish Medical Oncology Association

ENET(European Neuroendocrine Tumour Society)

ESMO

ASCO

Personal information

Title: Professor Doctor

Branch: Radiation Oncology

Work History:

1 GATA Military Medical Faculty

2 Gayrettepe Florence Nightingale Hospital

3 T.R. Demiroğlu Bilim University \ Associate Professor

4 T.R Demiroğlu Bilim University \ Professor

Medical Specialties and Subspecialties:

1 Head and Neck Cancers

2 Radiation Oncology

Priority treatments:

1 Prostate cancer

2 Conformal treatments

Special advanced health technologies:

1 Truebeam Stx Technology

2 Halcyons

Education

1991 - Istanbul University Istanbul Faculty of Medicine

1996 - Istanbul University Cerrahpaşa Faculty of Medicine Radiation

Oncology Specialization Training

Experience

2022 PRIVATE MEDIPOL BAHÇELİEVLER HOSPITAL

2021 - 2021 Prof. Dr. Cemil Taşçıoğlu City Hospital, Medical Oncology Clinic Education Officer

2021 - 2021 Prof. Dr. Cemil Taşçıoğlu City Hospital

2020 - 2021 Yüzüncü Yıl University Faculty of Medicine

2020 - 2021 Head of the Department of Medical Oncology, Yüzüncü Yıl University Faculty of Medicine, Assoc. Dr.  

2018 - 2021 Lecturer - Yüzüncü Yıl University Faculty of Medicine, Head of Medical Oncology Department  

2018 - 2021 Yüzüncü Yıl University Faculty of Medicine

2015 - 2018 University of Health Sciences, Okmeydanı Training and Research Hospital

2015 - 2018 University of Health Sciences, Okmeydanı Training and Research Hospital, Medical Oncology Clinic, Sub-branch assistant

2012 - 2015 Kanuni Sultan Süleyman Training and Research Hospital, Internal Medicine specialist

2012 - 2015 Suleiman the Magnificent Training and Research Hospital,

2008 - 2012 Haseki Training and Research Hospital

2006 - 2008 Kızıltepe No. 3 Health Center General Practitioner.

Education

2018

İstanbul Okmeydanı Eğitim ve Araştırma Hastanesi, Tıbbı Onkoloji

2018

İstanbul Okmeydanı Eğitim ve Araştırma Hastanesi, Tıbbı Onkoloji, İstanbul Okmeydanı Eğitim ve Araştırma Hastanesi, Tıbbı Onkoloji

2012

İstanbul Haseki Eğitim ve Araştırma Hastanesi, İç Hastalıkları, İstanbul Haseki Eğitim ve Araştırma Hastanesi, İç Hastalıkları

2012

İstanbul Haseki Eğitim ve Araştırma Hastanesi, İç Hastalıkları

2007

Uludağ Üniversitesi Tıip Fakültesi, Tıip Fakültesi, Uludağ Üniversitesi Tıip Fakültesi, Tıip Fakültesi

Il professor Yildirim è specializzato in immunoterapia del cancro e terapie mirate, con oltre 80 pubblicazioni in oncologia.

• Membro della Società Europea di Oncologia Medica (ESMO)
• Esperto in tumori della mammella, gastrointestinali e polmonari
• Professore presso l'Università Halic, docente per futuri oncologi
• Autore di capitoli nel 'Manuale di Trattamento Avanzato per la Cura del Cancro'

Il dottor Ari Raphael guida l'Iniziativa Nazionale di Medicina Genomica presso il Sourasky Medical Center, specializzandosi in trattamenti oncologici avanzati.

• Docente senior con ampie ricerche in genomica e informatica biomedica
• Investigatore principale per molteplici studi clinici sul cancro al polmone e alla mammella
• Membro della Società Europea di Oncologia Medica (ESMO) e dell'Associazione Internazionale per lo Studio del Cancro al Polmone (IASLC)
• Vincitore di numerosi riconoscimenti per l'insegnamento e la ricerca

Il Dr. Jaume Capdevila ha effettuato oltre 1.100 trattamenti per pazienti oncologici, specializzandosi in casi di cancro avanzato presso il Centro Médico Teknon.

• 24 anni di esperienza in oncologia
• Riconosciuto a livello internazionale per il lavoro innovativo in casi complessi come la carcinosi
• Membro di numerose prestigiose società oncologiche, tra cui ESMO e ASCO
• Co-fondatore del Gruppo di Lavoro Spagnolo per Tumori Orfani e Rari

Dr. Rahib Hasanov is a medical oncologist. He graduated from Istanbul University Cerrahpaşa Faculty of Medicine (1999–2005). He completed an internal medicine residency (2009–2013) and a medical oncology fellowship at Marmara University (2015–2018). He also completed an observership at Houston Methodist Hospital (2006–2007).

He focuses on personalized oncology. His treatments include immunotherapy, targeted therapy, and novel agents. His clinical interests include gastrointestinal, breast, lung, and genitourinary cancers.

He attends national and international conferences. He welcomes patients from Turkey, Azerbaijan, Montenegro, Georgia, Uzbekistan, the Middle East, Europe, and the United States.